OTCMKTS:KMLXF

Respiri (KMLXF) Stock Price, News & Analysis

$0.01
0.00 (0.00%)
(As of 04/23/2024 ET)
Today's Range
$0.01
$0.01
50-Day Range
$0.01
$0.01
52-Week Range
$0.04
$0.05
Volume
N/A
Average Volume
6,100 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Respiri

Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia and Israel. The company develops, produces, and sells mobile health applications. Its products include Wheezo, an asthma management tool to help user understand their asthma by providing information, such as triggers, symptoms, medication usage, and other events. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited is based in Melbourne, Australia.

KMLXF Stock Price History

KMLXF Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive KMLXF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Respiri and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/23/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Private Households
Sub-Industry
N/A
Current Symbol
OTCMKTS:KMLXF
CIK
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.07 million

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.07
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Nicholas Smedley
    Exec. Chairman
  • Mr. Marjan Mikel B.Sc.
    M.A.I.C.D., CEO, MD & Exec. Director
  • Mr. Theo Antonopoulos
    Chief Commercial Officer
  • Mr. Philippe Ludekens
    Gen. Mang. of Commercial Operations
  • Ms. Jan P. Barker
    Vice-Pres of Bus. Devel.
  • Mr. Alastair Beard
    Company Sec.
  • Prof. Noam Gavriely
    Medical & Scientific Advisor
  • Mr. Simon Godfrey
    Medical & Scientific Advisor

KMLXF Stock Analysis - Frequently Asked Questions

How have KMLXF shares performed in 2024?

Respiri's stock was trading at $0.01 at the beginning of the year. Since then, KMLXF stock has increased by 0.0% and is now trading at $0.01.
View the best growth stocks for 2024 here
.

How do I buy shares of Respiri?

Shares of KMLXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:KMLXF) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners